FDA Expands Approval of Gilenya to Treat MS in Paediatric Patients

The US Food and Drug Administration (FDA) has approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents aged 10 years and older. This is the first FDA approval of a drug to treat MS in paediatric patients. ‘For the first time, we have an FDA-approved treatment specifically for children and adolescents [...]

By |2018-05-15T11:33:09+00:00May 16th, 2018|Regional News|0 Comments

NPA Announces New Fundraising Efforts

The National Pharmacy Association (NPA) is selling an exclusive range of Community Pharmacy Works clothing items, including socks, cufflinks and t-shirts, with all proceeds going to the charity, Pharmacist Support. Pharmacist Support provides help in times of need for pharmacists and their families, former pharmacists, and pharmacy students. NPA Head of Communications, Stephen Fishwick, explained, [...]

By |2018-05-15T11:36:10+00:00May 16th, 2018|Regional News|0 Comments

A New Drug Shows Pre-Clinical Efficacy in Rett Syndrome

A new article published in the Cell Reports describes how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett Syndrome in pre-clinical models. The study, led by Dr Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA [...]

By |2018-05-15T11:37:05+00:00May 16th, 2018|Regional News|0 Comments